ARWR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Arrowhead Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 67.08 USD -0.97% Market Closed

Market Cap: $9.4B

	Arrowhead Pharmaceuticals Inc NASDAQ:ARWR	US
S	Simon Property Group Inc F:SQI	US

Profitability Summary

Arrowhead Pharmaceuticals Inc's profitability score is 12/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-34%

Negative 3Y Average Operating Margin

-3.866%

Operating Margin is Increasing

-70% > -34%

Negative Net Margin

-48%

Negative 3Y Average Net Margin

-3.912%

Net Margin is Increasing

-71% > -48%

Negative Free Cash Flow Margin

-11%

Negative 3Y Average Free Cash Flow Margin

-3.686%

Free Cash Flow Margin is Increasing

-134% > -11%

Negative ROE

-65%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-66%

ROIC is Increasing

-55% > -52%

View All

Hide

Collapse

12 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.